Related Experiment Video
Updated: Feb 10, 2026

Multilevel Oblique Lumbar Interbody Fusion in Degenerative Lumbar Disc Disease with Instability
Published on: July 25, 2025
Neurotrophic factor therapy for nervous system degenerative diseases
1Department of Neuroscience, Genentech Inc., South San Francisco, California 94080.
Neurotrophic factors show promise for treating neurodegenerative diseases by supporting neuronal survival and plasticity. Research is exploring their therapeutic potential for conditions like Alzheimer's, Parkinson's, and spinal cord injuries.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Neurotrophic factors regulate neuronal survival and plasticity.
- Neurodegenerative diseases involve neuronal loss and dysfunction.
Purpose of the Study:
- To explore the therapeutic potential of neurotrophic factors in treating neurodegenerative diseases.
- To identify specific neurotrophic factors for various neurological conditions.
Main Methods:
- Review of existing research on neurotrophic factors and neurodegenerative diseases.
- Identification of neurotrophic factors relevant to specific conditions.
- Exploration of delivery strategies and therapeutic molecule development.
Main Results:
- Neurotrophic factors like NGF and neurotrophin-3 are candidates for peripheral neuropathies.
- IGF and CNTF show potential for motor neuron atrophy.
- NGF is being investigated for Alzheimer's disease.
Conclusions:
- Neurotrophic factors offer a promising therapeutic avenue for neurodegeneration.
- Targeted delivery and development of mimetic molecules are key research areas.
Related Concept Videos
What is a Nervous System?
The Parasympathetic Nervous System
The Sympathetic Nervous System
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gene Therapy

